Introduction Sub-Saharan Africa (SSA) continues to face a significant burden of HIV/AIDs, with about 20.8 million People Living with HIV (PLHIV) and approximately 450,000 new infections in 2023.1 As the lifespan of PLHIV increases due to the availability of Antiretroviral Therapy (ART),2 there is a notable rise in cardiovascular disease-related mortality among them,3,4 with hypertension (HTN) being the leading risk factor.5,6 PLHIV and HTN have a significantly increased risk of mortality...